Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

4420456374_64a3d7e6aa_88_2

Top Ten most popular articles on Pharmafile.com this week

January 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, European Commission, FDA, Pakistan, Sanofi, Teva

Pakistan is cracking down on corruption and has registered cases against 200 pharmaceutical companies, while in the US the FDA …
News
abbvie_0

AbbVie’s Skyrizi outpaces Novartis’ Cosentyx in plaque psoriasis skin clearance

January 16, 2020 Research and Development AbbVie, Cosentyx, Novartis, Skyrizi, pharma, psoriasis

AbbVie has made it known that Skyrizi (risankizumab) outpaced Novartis’ Cosentyx (secukinumab) at Phase 3 in the treatment of plaque …
News
dw-anzcxqaqavhl

FDA approves Lannett’s cocaine-based nasal spray

January 15, 2020 Research and Development FDA, Lannett, Numbrino, cocaine

It has been announced that the FDA has moved to approve Lannett Company’s Numbrino (cocaine hydrochloride) nasal solution for “the …
News
40542895134_9f6048fa40_b

FDA panel votes against Nektar opioid painkiller

January 15, 2020 Research and Development Bernie Opioids, Big Pharma, Trump opioids, opioid, opioid crisis, opioids, pharma

FDA unanimously voted against Nektar Therapeutics opioid pankiller (NKTR-181) for chronic lower back pain, prompting the company to withdraw its …
News

Pfizer’s Ibrance combo authorised via the Cancer Drugs Fund for advanced breast cancer

January 15, 2020 Research and Development Cancer Drugs Fund, NICE, Pfizer, ibrance, pharma

NICE, the drug watchdog for England and Wales, has given its approval for Pfizer’s Ibrance (palbociclib) in combination with AstraZeneca’s …
News
131224-f-im476-001

Rochester Drug Cooperative ceases opioid sales following criminal charges

January 15, 2020 Research and Development Bernie Sanders, Trump opioids, opioid, opioid crisis, opioids

The Rochester Drug Cooperative (RDC) has announced it will no longer distribute opioid medications after two of its executives were …
News
48721589102_164e25393b_b

Democrat Presidential Candidates pledge to lower drug prices without Congress’ help

January 15, 2020 Research and Development Bernie Sanders, GOP, Trump, US President, US Presidential Election, democrats, republican

Two Democratic presidential candidates said that if they are elected president they will act immediately to reduce the cost of …
News
jp-kress_mor

Working Life Interview: Jean-Paul Kress, CEO of MorphoSys

January 13, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Working Life, feature, morphosys, pharma

With a medical doctorate as well as degrees in pharmacology and immunology under your belt, was your path always to …
Feature
4420456374_64a3d7e6aa_88

Top Ten most popular articles on Pharmafile.com this week

January 10, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The US pharamaceutical industry dominates the news this week, with Pfizer, Sanofi and GlaxoSmithKline all increasing their drug prices while …
News
novartis_window

Novartis’ ligelizumab tops Xolair in chronic spontaneous urticaria

January 9, 2020 Research and Development Novartis, Xolair, ligelizumab

Novartis has provided a burst of new data directly comparing its therapy ligelizumab with the current standard of care Xolair …
News
nmpa_logo

China approves first homegrown HPV vaccine

January 8, 2020 Research and Development, Sales and Marketing China, HPV, NMPA, pharma, vaccines

Female patients in China between the ages of nine and 45 will have access to the country’s first domestically-produced vaccine …
News
26795071995_1a72be4ca3_b

No link between talc and ovarian cancer, new study reveals

January 8, 2020 Research and Development . Johnson & Johnson, Johnson & Johnson, baby powder, talc, talc powder

Researchers examining data from over 252,000 women have concluded that there is no statistically significant link between the use of …
News
shutterstock

Apellis therapy outflanks Alexion’s Soliris in head-to-head paroxysmal nocturnal haemoglobinuria

January 8, 2020 Research and Development Alexion, Appelis, pegcetacoplan, pharma, soliris

Apellis Pharmaceuticals has revealed new Phase 3 demonstrating that its targeted C3 inhibitor pegcetacoplan met its primary endpoint and outclassed …
News
14281921538_bacbef11bc_b

Pharmacies argue that prescribers bear ultimate responsibility for the opioid crisis

January 8, 2020 Research and Development Bernie Sanders, OxyContin, opioid crisis, opioids

Pharmacy chains have argued in federal court that doctors and healthcare practitioners who write prescriptions bear ultimate responsibility for the …
News
abbottweb

FDA approves alternative approach for Abbot HeartMate 3 heart pump

January 8, 2020 Research and Development Abbott, FDA, Heart Pump, US Pharma, heart disease

The FDA announced today that it has approved a new alternative surgical technique for Abbot’s HeartMate 3 heart pump. The …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026